Skip to content

Clinical trials

Phase 3 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 3 Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20021
20032
20042
20052
20061
20073
20082
20092
20104
20112
20122
20132
20151
20164
20174
20193
202021
20217
20228
20232
20243
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated30
Unknown status12
Recruiting12
Withdrawn5
Not yet recruiting4
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
NICHD Neonatal Research Network7
University of Turin, Italy3
Assistance Publique - Hôpitaux de Paris2
Centre Hospitalier St Anne2
Centre Hospitalier Universitaire de Besancon2
Massachusetts General Hospital2
Negovsky Reanimatology Research Institute2
ONY2
Southeast University, China2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome105
COVID-1922
Acute Lung Injury12
Premature Birth12
Respiratory Insufficiency12
Lung Diseases11
Coronavirus Infections9
Pneumonia9
Severe Acute Respiratory Syndrome7
Bronchopulmonary Dysplasia5

Trials

Showing 51 to 75 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.